The Quantellect read.As of Nov 19, 2026, 10 active firms cover Roivant Sciences Ltd: 9 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $40.00 to $55.00, so the covering firms are broadly aligned. The average target of $48.14 sits 24% above the current $38.74. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.34 next quarter toward $-1.43 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 active firms
Buy
Strong Buy00%
Buy990%
Neutral110%
Sell00%
Strong Sell00%
Based on 10 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$48.14
+24.3% upside
Average target across 7 active firms as of Nov 19, 2026 vs $38.74 current
Highest Target$55.00
Average Target$48.14
Lowest Target$40.00
Detailed analyst forecasts for ROIV
Showing 1–8 of 8 named analysts shown · 10 active firms in the rating projection
As of Nov 19, 2026, 9 of 10 active firms rate ROIV a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ROIV EPS & revenue forecast
EPS · NEXT QUARTER
$-0.34
Range $-0.38 – $-0.28 · 2 analysts · +6% YoY
Next period, 2 analysts expect Roivant Sciences Ltd to earn $-0.34 a share (range $-0.38 – $-0.28), versus $-0.32 a year earlier. Full-year consensus is $-1.12, growing to $-1.43 the year after.
REVENUE · NEXT QUARTER
$75.1M
Range $40.5M – $97.0M · 2 analysts · +2881% YoY
Revenue is expected to reach $75.1M (range $40.5M – $97.0M), +2880.9% year-over-year. Full-year consensus is $162.7M, rising to $604.5M next year.
Top analysts covering Roivant Sciences Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ROIV.
#1
Yatin Suneja
Guggenheim · Rank #84
Buy
$46.00+18.7% to target
Overall win rate
50%
+ Follow
#2
Brian Cheng
JP Morgan · Rank #87
Buy
No targeton ROIV
Overall win rate
51%
+ Follow
#3
Douglas Tsao
HC Wainwright & Co. · Rank #312
Buy
$47.00+21.3% to target
Overall win rate
35%
+ Follow
#4
SS
Samantha Semenkow
Citigroup · Rank #333
Buy
$56.00+44.6% to target
Overall win rate
41%
+ Follow
#5
Yasmeen Rahimi
Piper Sandler · Rank #339
Buy
$40.00+3.3% to target
Overall win rate
30%
+ Follow
ROIV stock forecast FAQ
What is ROIV's average 12-month price target?+
The 7 active firms with a live target average $48.14 for Roivant Sciences Ltd over the next 12 months, ranging from a $55.00 high to a $40.00 low, as of Nov 19, 2026.
Is ROIV stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 10 active firms as of Nov 19, 2026, 9 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ROIV?+
The Street-high target is $55.00 (TD Cowen), and the Street-low is $40.00 (Piper Sandler). The average of all 7 active-firm targets is $48.14.
How many active Wall Street firms cover ROIV?+
10 active firms have a recognized rating on Roivant Sciences Ltd as of Nov 19, 2026, and 7 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ROIV?+
Among analysts who currently cover ROIV, Yatin Suneja of Guggenheim has the strongest overall Quantellect track record (Rank #84). Their current call is Buy with a $46.00 target.
What is Roivant Sciences Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.34 per share (range $-0.38 – $-0.28) across 2 analysts. Full-year EPS is projected at $-1.12, rising to $-1.43 the following year.
How much revenue is Roivant Sciences Ltd expected to report next quarter?+
Consensus revenue is $75.1M (range $40.5M – $97.0M). Full-year revenue is projected at $162.7M, growing to $604.5M next year.
Have analysts been upgrading or downgrading ROIV lately?+
As of Nov 19, 2026, 9 of 10 active firms rate ROIV a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ROIV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.